Genzyme Corp. (Nasdaq: GENZ) reports Q4 EPS of $0.91, ex-items, versus the consensus of $0.92. Revenues came ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE